Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.
J Clin Hypertens (Greenwich)
; 26(1): 5-16, 2024 01.
Article
in En
| MEDLINE
| ID: mdl-37667532
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Leukemia, Myeloid, Acute
/
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
/
Hypertension
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Clin Hypertens (Greenwich)
Journal subject:
ANGIOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
United States